HYDROFARM HOLDINGS GROUP, INC. quarterly report, Q1 FY2023

Hydrofarm Holdings Group, Inc. — Q1 2023 Form 10-Q

Reporting period: Three months ended March 31, 2023. Hydrofarm manufactures and distributes controlled-environment agriculture equipment and supplies, primarily in the United States and Canada. Unless noted otherwise, dollar amounts are in millions.

Financial performance

MetricQ1 2023Q1 2022Change
Net sales$62.2$111.4Down 44.2%
Gross profit / margin$11.4 / 18.3%$16.6 / 14.9%Profit down 31.5%; margin up 3.4 percentage points
Operating loss$13.1$26.4Improved $13.3
Net loss$16.8$23.3Improved $6.4
Net loss per diluted share$0.37$0.52Improved $0.15
Cash used in operations$9.0$10.2Improved $1.2

Sales fell mainly because product volume declined 42.5%, which management attributed primarily to oversupply in the cannabis industry. Price and mix fell 1.1%, and foreign exchange reduced sales 0.6%. Gross margin improved partly because the prior-year period included acquisition-related costs and higher inventory allowances, and because of greater proprietary-brand sales and improved productivity. Current-period margin included restructuring costs and higher freight and labor costs as a percentage of sales. SG&A declined to $24.4 million from $40.2 million, including lower amortization and expenses associated with cost-saving efforts. Interest expense rose to $3.7 million from $2.4 million, primarily due to higher variable rates.

Financial position and liquidity

  • Cash was $18.7 million at March 31, 2023, down from $21.3 million at year-end 2022. Current assets were $150.8 million and current liabilities were $37.2 million.
  • Total debt was $118.7 million, including a $123.4 million outstanding Term Loan principal balance; the revolving facility had no borrowings. The Term Loan’s effective interest rate was 10.97% in Q1.
  • The revolving facility commitment was reduced to $55 million and its maturity extended to June 30, 2026. The company reported approximately $39 million available to borrow before the minimum fixed-charge coverage covenant would apply. It reported compliance with debt covenants at quarter-end.
  • Operating cash use was $9.0 million; investing cash use was $1.6 million, primarily capital expenditures. Financing provided $8.0 million, principally from an $8.6 million Eugene property sale-leaseback. Cash declined by $2.6 million during the quarter.

Material changes, outlook, and risks

  • Management cited agricultural oversupply and continuing adverse market conditions as principal pressures on demand, sales, and profitability; the duration and severity remain uncertain.
  • The restructuring plan narrows the primary product portfolio by approximately one-third and brands by approximately one-fifth, and consolidates facilities with related headcount reductions. Q1 restructuring charges were $1.4 million. The company estimated approximately $0.9 million of additional charges, primarily in Q2, and expected the plan as designed to be substantially complete in Q2. It estimated annualized savings of approximately $7 million, while noting results could differ and a further restructuring phase may be considered.
  • The company reported no formal revenue or earnings guidance. Management said cash, operating cash flows, and borrowing availability were expected to support operations and obligations for the next twelve months, but cautioned that sufficient cash generation or future borrowing availability cannot be assured. It is evaluating potential additional sale-leasebacks, asset sales, or equity financing if needed.
  • The Eugene property transaction generated $8.6 million of proceeds, but was accounted for as a failed sale-leaseback: the property remained recognized and a corresponding financial liability was recorded. The lease term is 15 years, with annual rent starting at approximately $0.7 million and rising to approximately $1.0 million.
  • Goodwill had been reduced to zero following a $189.6 million impairment recorded in June 2022. No impairment-triggering event was identified in Q1 2023. Inventory valuation, receivables, and future restructuring charges remain subject to estimates and market conditions.
  • Variable-rate Term Loan exposure is material: management estimated a 100-basis-point rate increase would raise annual interest expense by approximately $1.1 million. The company does not currently hedge interest-rate risk. Other stated risks include foreign-exchange movements, industry conditions, and potential loss or delayed access to deposits exceeding FDIC-insured limits.
  • The company reported no legal proceedings or claims it believed would have a material adverse effect, and stated disclosure controls were effective at quarter-end.

Investor facts to verify

  • Whether demand and sales trends stabilize as industry oversupply persists, and whether gross-margin gains can continue amid lower volume and cost pressures.
  • Whether restructuring is completed on schedule, achieves the estimated savings, and avoids additional charges or a second phase.
  • Cash generation, revolver availability, covenant headroom, and the ability to meet debt, lease, and working-capital requirements.
  • Exposure to variable interest rates and the implications of the Term Loan’s substantial principal repayment due in 2028.
  • Whether inventory reserves, receivable estimates, and the Eugene sale-leaseback accounting and reinvestment plans develop as described.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.